Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Formulary approaches may drive utilization of one or the other drug, both of which offer strong weight loss potential Employees should continue to monitor this class of medications as there are additional products in the pipeline, including oral semaglutide for obesity, expected to be FDA approved by the end of 2025
As someone with a history of Crohns, a type of inflammatory bowel disease (IBD), I already deal with a lot of GI issues
Over 80% of commercial insurers provide some coverage for weight loss medications, though terms vary by insurance plan
Some pharmacies are still getting compounded medications
US$ 21.36
US$ 24.47
US$ 26.68
US$ 21.41
US$ 26.28
US$ 23.91
